Assessment of exposure to tobacco smoke: measurement of exhaled carbon monoxide and hair nicotine

Aim: To investigate the effect of tobacco smoke (TS) exposure on the quantity of exhaled carbon monoxide (eCO) and hair nicotine (HN) and to evaluate the relationship between these values. Materials and methods: Included in the study were 96 subjects (64 male, 32 female) divided into 3 groups. The subjects in Group 1 (n = 46) were current smokers, and the subjects in Group 2 (n = 20) and Group 3 (n = 30) were nonsmokers with or without environmental TS exposure, respectively. The eCO level of all of the subjects was measured with a breath CO monitor. Gas chromatography/mass spectrometry were used for quantification of the HN (n = 47). Results: The mean age of the subjects was 39.1 years. The mean levels of eCO were 9.3 ppm, 1.3 ppm, and 1.0 ppm and the mean HN concentrations were 20.9 ng/mg, 2.1 ng/mg, and 0.7 ng/mg in the 3 groups, respectively. There was a significant difference between Group 1 and the other groups according to the levels of eCO and HN concentrations, but the levels of eCO and HN concentrations were similar in Group 2 and Group 3. There was a positive correlation between the levels of eCO and the HN concentrations. The cutoff values of eCO and HN for smokers were 6 ppm and 4 ng/mg, respectively. Conclusion: Although nicotine analysis in some biological samples like hair is specific to TS exposure, these methods are expensive and difficult procedures. Our results suggest that instead of HN analysis, a cheap and easy method like eCO measurement may be used, but further studies with more cases are needed.

Assessment of exposure to tobacco smoke: measurement of exhaled carbon monoxide and hair nicotine

Aim: To investigate the effect of tobacco smoke (TS) exposure on the quantity of exhaled carbon monoxide (eCO) and hair nicotine (HN) and to evaluate the relationship between these values. Materials and methods: Included in the study were 96 subjects (64 male, 32 female) divided into 3 groups. The subjects in Group 1 (n = 46) were current smokers, and the subjects in Group 2 (n = 20) and Group 3 (n = 30) were nonsmokers with or without environmental TS exposure, respectively. The eCO level of all of the subjects was measured with a breath CO monitor. Gas chromatography/mass spectrometry were used for quantification of the HN (n = 47). Results: The mean age of the subjects was 39.1 years. The mean levels of eCO were 9.3 ppm, 1.3 ppm, and 1.0 ppm and the mean HN concentrations were 20.9 ng/mg, 2.1 ng/mg, and 0.7 ng/mg in the 3 groups, respectively. There was a significant difference between Group 1 and the other groups according to the levels of eCO and HN concentrations, but the levels of eCO and HN concentrations were similar in Group 2 and Group 3. There was a positive correlation between the levels of eCO and the HN concentrations. The cutoff values of eCO and HN for smokers were 6 ppm and 4 ng/mg, respectively. Conclusion: Although nicotine analysis in some biological samples like hair is specific to TS exposure, these methods are expensive and difficult procedures. Our results suggest that instead of HN analysis, a cheap and easy method like eCO measurement may be used, but further studies with more cases are needed.

___

  • Brundtland GH. Achieving worldwide tobacco control. JAMA 2000; 284: 750-1.
  • McGinnis JM, Foege WH. Actual causes of death in the United States. JAMA 1993; 270: 2207-12. 3. West RR. Smoking: its infl uence on survival and cause of death. J Roy Coll Phys London 1992; 26: 357-66.
  • US Department of Health and Human Services. Th e health benefi ts of smoking cessation: a report of the surgeon general, 1990. Washington (DC): Department of Health and Human Services; 1990. Available at http://profi les.nlm.nih.gov/NN/B/ B/C/T/_/nnbbct.pdf.
  • California Environmental Protection Agency. Health eff ects of exposure to environmental tobacco smoke. Final report. Sacramento (CA): California Environmental Protection Agency, Offi ce of Environmental Health Hazard Assessment; 1997. Available at http://oehha.ca.gov/air/environmental_ tobacco/fi nalets.html.
  • Berny C, Boyer JC, Capolaghi B, De L’Homme G, Desch G, Garelik D et al. [Biomarkers of tobacco smoke exposure]. Ann Biol Clin 2002; 60: 263-72 (article in French).
  • Ishiyama I, Nagai T, Toshida S. Detection of basic drugs (methamphetamine, antidepressants, and nicotine) from human hair. J Forensic Sci 1983; 28: 380-5.
  • Al-Delaimy WK. Hair as a biomarker for exposure to tobacco smoke. Tob Control 2002; 11: 176-82.
  • Uematsu T. Utilization of hair analysis for therapeutic drug monitoring with a special reference to ofl oxacin and to nicotine. Forensic Sci Int 1993; 63: 261-8.
  • Centers for Disease Control and Prevention, Coordinating Center for Health Promotion, National Center for Chronic Disease Prevention, and Health Promotion Offi ce on Smoking and Health. Th e health consequences of involuntary exposure to tobacco smoke: a report of the Surgeon General, 2006. Washington (DC): Department of Health and Human Services; 2006. Available atwww.surgeongeneral.gov/library/ secondhandsmoke/report/executivesummary.pdf.
  • Warren CW, Jones NR, Eriksen MP, Asma S. Patterns of global tobacco use in young people and implications for future chronic disease burden in adults. Lancet 2006; 367: 749-53.
  • Okoli CT, Hall LA, Rayens MK, Hahn EJ. Measuring tobacco smoke exposure among smoking and nonsmoking bar and restaurant workers. Biol Res Nurs 2007; 9: 81-9.
  • Middleton ET, Morice AH. Breath carbon monoxide as an indication of smoking habit. Chest 2000; 117: 758-63.
  • Jarvis MJ, Tunstall-Pedoe H, Feyerabend C, Vesey C, Saloojee Y. Comparison of tests used to distinguish smokers from nonsmokers. Am J Public Health 1987; 77: 1435-8.
  • Jarvis MJ, Belcher M, Vesey C, Hutchison DCS. Low cost carbon monoxide monitors in smoking assessment. Th orax 1986: 41; 886-7.
  • Deveci SE, Deveci F, Açik Y, Ozan AT. Th e measurement of exhaled carbon monoxide in healthy smokers and non- smokers. Respir Med 2004; 98: 551-56.
  • Şahbaz S, Kılınç O, Günay T, Ceylan E. Th e eff ects of environmental tobacco smoke exposure before starting to smoke on cigarette quitting therapies. Tuberk Toraks 2008; 56: 283-90.
  • Guneser S, Atici A, Alparslan N, Cinaz P. Eff ects of indoor environmental factors on respiratory systems of children. J Trop Pediatr 1994; 40: 114-6.
  • Fidan F, Guven H, Eminoglu O, Kalkan S, Ergor G, Cimrin A. Turkish coff eehouse kahvehane is an important tobacco smoke exposure area in Turkey. J Toxicol Environ Health A 2005; 68: 1371-7.
  • Zahlsen K, Nilsen OG. Gas chromatographic analysis of nicotine in hair. Environ Technol 1990; 11: 353-64.
  • Man CN, Ismail S, Harn GL, Lajis R, Awang R. Determination of hair nicotine by gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2009; 877: 339- 42.
  • Kintz P, Ludes B, Mangin P. Evaluation of nicotine and cotinine in human hair. J Forensic Sci 1992; 37: 72-6.
  • Zahlsen K, Nilsen OG. Nicotine in hair of smokers and non- smokers: sampling procedure and gas chromatographic/mass spectrometric analysis. Pharmacol Toxicol 1994; 75: 143-9.
  • Kintz P. Gas chromatographic analysis of nicotine and cotinine in hair. J Chromatogr 1992; 580: 347-53.
  • Chetiyanukornkul T, Toriba A, Kizu R, Kimura K, Hayakawa K. Hair analysis of nicotine and cotinine for evaluating tobacco smoke exposure by liquid chromatography-mass spectrometry. Biomed Chromatogr 2004; 18: 655-61.
  • Zahlsen K, Nilsen T, Nilsen OG. Interindividual diff erences in hair uptake of air nicotine and signifi cance of cigarette counting for estimation of environmental tobacco smoke exposure. Pharmacol Toxicol 1996; 79: 183-90.
  • Nafstad P, Jaakkola JJK, Hagen JA, Zahlsen K, Magnus P. Hair nicotine concentrations in mothers and children in relation to parental smoking. J Expo Anal Environ Epidemiol 1997; 7: 235-9.
  • Gerstenberg B, Schepers G, Voncken P, Völkel H. Nicotine and cotinine accumulation in pigmented and unpigmented rat hair. Drug Metab Dispos 1995; 23: 143-8.
  • Eliopoulos C, Klein J, Koren G. Validation of self-reported smoking by analysis of hair for nicotine and cotinine. Th er Drug Monit 1996; 18: 532-6.
  • Al-Delaimy WK, Crane J, Woodward A. Questionnaire and hair measurement of exposure to tobacco smoke. J Expo Anal Environ Epidemiol 2000; 10: 378-84.
  • Chatkin J, Fritscher L, de Abreu C, Cavalet-Blanco D, Chatkin G, Wagner M et al. Exhaled carbon monoxide as a marker for evaluating smoking abstinence in a Brazilian population sample. Prim Care Respir J 2007; 16: 36-40.
  • Bıçak M, Özkan M, Yüksekol İ, Tozkoparan E, Balkan A, Ekiz K et al. Importance of measuring exhaled carbon monoxide in asthma and COPD. Toraks Dergisi 2003; 4: 231-5 (article in Turkish).
  • Zayasu K, Sekizawa K, Okinaga S, Yamaya M, Ohrui T, Sasaki H. Increased carbon monoxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med 1997; 156: 1140-3.
  • Yamaya M, Hosoda H, Ishizuka S, Monma M, Matsui T, Suzuki T et al. Relation between exhaled carbon monoxide levels and severity of asthma. Clin Exp Allergy 2001; 31: 417-22.
  • Temel O, Coşkun AŞ, Gök Ş, Çelik P, Yorgancıoğlu A. Th e eff ect of nicotine among active, passive smoker health personnel. Toraks Dergisi 2009; 10: 107-11 (article in Turkish).
  • Woźniak K, Moes A, Chadzyński R, Domagała-Kulawik J. [Evaluation of the indication of carbon monoxide in exhaled air]. Przegl Lek 2009; 66: 632-5 (article in Polish).
  • Cunnington AJ, Hormbrey P. Breath analysis to detect recent exposure to carbon monoxide. Postgrad Med J 2002; 78: 233-7.
  • Shafi q M, Khan S, Khawaja MR, Haque S, Khan JA. Socio- demographic correlates of exhaled breath carbon monoxide in Karachi’s adult population. J Pak Med Assoc 2008; 58: 75-8.
  • Fritz M, Wallner R, Grohs U, Kemmler G, Saria A, Zernig G. Comparable sensitivities of urine cotinine and breath carbon monoxide at follow-up time points of three months or more in a smoking cessation trial. Pharmacology 2010; 85: 234-40.
  • Underner M, Ingrand P, Favreau M, Mura P, Meurice JC. [Usefulness of biological markers in the evaluation of smoking at the fi rst visit of a smoking cessation program]. Rev Mal Respir 2004; 21: 705-10 (article in French).
Turkish Journal of Medical Sciences-Cover
  • ISSN: 1300-0144
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK
Sayıdaki Diğer Makaleler

Iodine deficiency in pregnancy and in women of reproductive age in Erzurum, Turkey

Metin İNGEÇ, Semra ÇETİNKAYA, Kadir ÇETİNKAYA, İbrahim KAPLAN

Bother index can be used in deciding how the symptom nocturia itself is important

Hacı İbrahim ÇİMEN, Ahmet Tunç ÖZDEMİR, Ege Can ŞEREFOĞLU, Ali Fuat ATMACA, Serkan ALTINOVA, Mevlana Derya BALBAY

The effects of the Cobra perilaryngeal airway on intraocular pressure

Lale KARABIYIK, Sema ÖNCÜL, Gökçen EMMEZ

Effects of neoadjuvant chemotherapy on pathological parameters and survival in patients undergoing radical cystectomy for muscle-invasive bladder cancer

Alper ÇAĞLAYAN, Ziya AKBULUT, Ali Fuat ATMACA, Serkan ALTINOVA, Metin KILIÇ, Mevlana Derya BALBAY

Comparison of anesthesia with sevofl urane-N2O and midazolam-remifentanil in low-birth-weight premature infants undergoing diode laser photocoagulation

Levent ÖZTÜRK, Eyüp HORASANLI, Abdulkadir BUT, Müge ARIKAN, Meltem TABUK, Bilge ASLAN

Isı Şok Protein İnhibitörü KNK437’nin Endotel Hücrelerinde Anjiyogenez Üzerine Etkisi

Mehmet ŞAHİN, Emel ŞAHİN, Saadet GÜMÜŞLÜ

Does the treatment of obstructive sleep apnea syndrome improve lower urinary tract symptoms?

Öner ODABAŞ, Metin YIĞMAN, Cavit CEYLAN

The impact of nephrometry score on partial nephrectomy rates and survival

Ali Barbaros BAŞESKİOĞLU, Yunus Saim Cavit CAN, Aydın YENİLMEZ, Coşkun KAYA

The effect of N-acetylcysteine on growth and biofi lm formation in Staphylococcus epidermidis strains

Sahra KIRMUSAOĞLU, Seyhun YURDUGÜL, M. Esra KOÇOĞLU

Cytotoxic effect of cigarette smoke condensate on mice and rat mesenchymal stem cells and HeLa cells

Aftab AHMAD, Abdul Rauf SHAKOORI